August 4, 2014 | EndyMed, an Israeli medical equipment developer creating equipment based on radio frequency technologies, signed an agreement with Chinese company OHMK Medical Technology for $7 million. OHMK will acquire 47.93 million EndyMed shares, giving OHMK a 37.21 percent stake in the company. OHMK markets EndyMed’s products EndyMed Glow and EndyMed Pro in China. Founded in 2007, EndyMed is a medical technology company specializing in the design, development and sale of energy based aesthetic treatments. The company’s products have been approved by the Food & Drug Administration in the United States and China.